From the *Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland
†Division of Pediatric Infectious Diseases, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland
‡Division of Medical Microbiology, Department of Pathology, The Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, Baltimore, Maryland
Accepted for publication February 17, 2023
J.M. received funding from the National Institutes of Health T32 (T32 AI052071). S.Z. received research funds from Vela Diagnostics and the Cystic Fibrosis Foundation.
The authors have no conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).
Address for correspondence: Alice J. Hsu, PharmD, BCPS, AQ-ID, The Johns Hopkins Hospital, 600 N. Wolfe Street, Carnegie 180, Baltimore, MD 21287. E-mail: [email protected].
